For the Inventor, By the Inventor

Enter assignee name

Brentford, Middlesex, United Kingdom

Cellzome Limited

USPTO Granted Patents = 21

CIPO Patents = 2

EPO Patents = 24

Forward Citations = 26

Loading Chart...

Loading Chart...

57 inventors (with patents filed for the assignee):

Henricus Jacobus Maria Gijsen (8 out of 39 patents)

Didier Jean-Claude Berthelot (7 out of 23 patents)

François Paul Bischoff (7 out of 16 patents)

4. Nigel Ramsden (7 out of 9 patents)

5. Sven Franciscus Anna Van Brandt (6 out of 38 patents)

6. Andrew David Cansfield (6 out of 12 patents)

7. Michel Anna Jozef De Cleyn (5 out of 19 patents)

8. Rosemary Lynch (5 out of 7 patents)

9. Mihiro Sunose (5 out of 8 patents)

10. Jeremy Major (5 out of 7 patents)

11. Adriana Ingrid Velter (4 out of 8 patents)

12. Serge Maria Aloysius Pieters (4 out of 27 patents)

13. Daniel Oehlrich (4 out of 16 patents)

14. Rita Adrego (4 out of 5 patents)

15. Michel Surkyn (4 out of 15 patents)

21 patents: Sort by Forward Citations

1. 9655897 - Heterocyclyl pyrimidine analogues as TYK2 inhibitors (2017-05-23),

2. 9296725 - Heterocyclyl pyrimidine analogues as TYK2 inhibitors (2016-03-29),

3. 9249129 - Morpholino substituted urea derivatives as mTOR inhibitors (2016-02-02),

4. 9242993 - Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mTOR inhibitors (2016-01-26),

5. 9242987 - Heterocyclyl pyrazolopyrimidine analogues as JAK inhibitors (2016-01-26),

6. 9181245 - Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's disease (2015-11-10),

7. 9145399 - Substituted bicyclic triazole derivatives as gamma secretase modulators (2015-09-29),

8. 9115143 - Substituted indole derivatives as gamma secretase modulators (2015-08-25),

9. 9079886 - Substituted triazole derivatives as gamma secretase modulators (2015-07-14),

10. 9040545 - Heterocyclyl pyrazolopyrimidine analogues as selective JAK inhibitors (2015-05-26),

11. 8987276 - Substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators (2015-03-24),

12. 8946426 - Substituted bicyclic heterocyclic compounds as gamma secretase modulators (2015-02-03),

13. 8946266 - Substituted triazole and imidazole derivatives as gamma secretase modulators (2015-02-03),

14. 8883820 - Triazole derivatives as kinase inhibitors (2014-11-11),

15. 8865699 - Amino triazoles as PI3K inhibitors (2014-10-21),

Cellzome Limited is a drug discovery and proteomics company, focused on identifying novel kinase drug targets for the development of personalized medicines. The company utilizes its proprietary technology platform to analyze protein interactions and post-translational modifications to identify potential drug targets. With a strong emphasis on innovative research and collaboration, Cellzome aims to accelerate the discovery of new therapies for a range of diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

21 Patents

#1 in Brentford, Middlesex

#842 in United Kingdom

#29,080 in the World

Brentford, Middlesex, United Kingdom

Cellzome Limited

Forward Citations = 26

57 inventors:

Henricus Jacobus Maria Gijsen (8 out of 39 patents)

Didier Jean-Claude Berthelot (7 out of 23 patents)

François Paul Bischoff (7 out of 16 patents)

4. Nigel Ramsden (7 out of 9 patents)

5. Sven Franciscus Anna Van Brandt (6 out of 38 patents)

Please report any incorrect information to support@idiyas.com

Loading…